MoneyWorks4Me

Ajanta Pharma - Quaterly Results

30 Apr 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 10139.40 millions, up 9.49% as compared to Rs. 9260.70 millions during the corresponding quarter last year.Modest increase of 18.89% in the Net Profit was reported from. 1626.90 millions to Rs. 1934.30  millions.Operating profit for the quarter ended March 2025 rose to 2675.80 millions as compared to 2608.30 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 10139.40 9260.70 9.49 43220.40 39711.20 8.84 43220.40 39711.20 8.84
Other Income 179.30 336.80 -46.76 1198.70 1164.80 2.91 1198.70 1164.80 2.91
PBIDT 2675.80 2608.30 2.59 13245.90 12359.10 7.18 13245.90 12359.10 7.18
Interest 6.70 14.20 -52.82 46.00 68.00 -32.35 46.00 68.00 -32.35
PBDT 2669.10 2594.10 2.89 13199.90 12291.10 7.39 13199.90 12291.10 7.39
Depreciation 387.60 334.70 15.81 1399.30 1321.60 5.88 1399.30 1321.60 5.88
PBT 2281.50 2259.40 0.98 11800.60 10969.50 7.58 11800.60 10969.50 7.58
TAX 347.20 632.50 -45.11 2631.70 2897.10 -9.16 2631.70 2897.10 -9.16
Deferred Tax -43.80 34.20 -228.07 51.40 121.30 -57.63 51.40 121.30 -57.63
PAT 1934.30 1626.90 18.89 9168.90 8072.40 13.58 9168.90 8072.40 13.58
Equity 250.70 252.70 -0.79 250.70 252.70 -0.79 250.70 252.70 -0.79
PBIDTM(%) 26.39 28.17 -6.30 30.65 31.12 -1.53 30.65 31.12 -1.53
Peers
Company Name CMP
Sun Pharma. Inds. 1861.75
Dr. Reddys Labs. 1172.60
Cipla 1379.35
Lupin 2079.45
Zydus Lifesciences 1137.05
View more..